Talk:Dipyridamole
From Wikipedia, the free encyclopedia
 |
Dipyridamole is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome. |
| Start | This article has been rated as Start-Class on the quality scale. |
| Low | This article has been rated as Low-importance for this Project's importance scale. |
|
|
|
 |
This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess. |
| Start | This page has been rated as Start-Class on the quality assessment scale |
| Low | This article has been rated as Low-importance on the importance assessment scale |
[edit] Coronary Steal
I would think that more attention should be given to coronary steal in this article. The quote below, taken from this article, suggests that administering Dipyridamole might be advantageous in the ischemic heart which would seem to be in contrast to the later statements about coronary steal.
"Dipyridamole treatment has shown to increase myocardial perfusion and left ventricular function in patients with ischemic cardiomyopathy." —Preceding unsigned comment added by Dr. Doof (talk • contribs) 02:37, 10 March 2008 (UTC)
[edit] Dipyridamole vs Dipyramidole
Is dipyramidole the same thing as dipyridamole? In one of my texts it reads "dipyramidole inhibits thromboxane synthase", and it doesn't seem like dipyridamole has that effect. Are those different compounds?
- Most likely a typo. Fvasconcellos (t·c) 12:51, 19 May 2007 (UTC)
